Vaccine approaches to treat urothelial cancer

Authors: Giulia Claire Giudice, Guru P. Sonpavde

Source: Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)

Subject Terms: Bladder cancer, urothelial cancer, cancer vaccine, peptide-based vaccine, DC-based vaccine, virus-based vaccine, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/b75cab40967143d3bd8d621846f00dc7

Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections

Authors: Nitish A. Kulkarni, Som G. Nanjappa

Source: Vaccines, Vol 12, Iss 9, p 981 (2024)

Subject Terms: dendritic cells, pulmonary fungal infections, DC-based vaccine, adaptive immune response, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-393X/12/9/981; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/155d47598ea34a279f7a9b1ff8f57d70

Impaired function of dendritic cells within the tumor microenvironment

Authors: Zhihua Xiao, Ruiqi Wang, Xuyan Wang, Haikui Yang, Jiamei Dong, Xin He, Yang Yang, Jiahao Guo, Jiawen Cui, Zhiling Zhou

Source: Frontiers in Immunology, Vol 14 (2023)

Subject Terms: dendritic cell, tumor microenvironment, immune tolerance, immunosuppressive populations, DC-based vaccine, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1213629/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/f31aad5ac0194c09ae87635ed4e15100

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine

Authors: Hyun Jin Park, Gun-Young Jang, Young Seob Kim, Jung Hwa Park, Sung Eun Lee, Manh-Cuong Vo, Je-Jung Lee, Hee Dong Han, In Duk Jung, Tae Heung Kang, Yeong-Min Park

Source: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)

Subject Terms: Dendritic cell (DC), Toll-like receptor 4 (TLR4), DC based vaccine, 40S ribosomal protein S3 (RPS3), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-019-0539-7; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/1cd143757e744b09a088290bbaa52a8e

Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer

Authors: Ayesha B. Alvero, Douglas Hanlon, Mary Pitruzzello, Renata Filler, Eve Robinson, Olga Sobolev, Roslyn Tedja, Alessandra Ventura, Marcus Bosenberg, Patrick Han, Richard L. Edelson, Gil Mor

Source: OncoImmunology, Vol 9, Iss 1 (2020)

Subject Terms: ovarian cancer, immunotherapy, dc-based vaccine, transimmunization, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2162-402X

Access URL: https://doaj.org/article/9887764f3ef24c5c98a8fced536f8082

Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma

Authors: Lenka Fedorova, Peter Mudry, Katerina Pilatova, Iveta Selingerova, Jana Merhautova, Zdenek Rehak, Dalibor Valik, Eva Hlavackova, Dasa Cerna, Lucie Faberova, Pavel Mazanek, Zdenek Pavelka, Regina Demlova, Jaroslav Sterba, Lenka Zdrazilova-Dubska

Source: Frontiers in Oncology, Vol 9 (2019)

Subject Terms: dendritic cells, anticancer immunotherapy, dendritic-cell (DC)-based vaccine, pediatric sarcoma, academic clinical trials, immunomonitoring, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fonc.2019.01169/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/c3ae2baabd0d44bdbcc5b4dc91aed1c5

T-Regulatory Cells and Vaccination 'Pay Attention and Do Not Neglect Them': Lessons from HIV and Cancer Vaccine Trials

Authors: Vedran Brezar, Véronique Godot, Liang Cheng, Lishan Su, Yves Lévy, Nabila Seddiki

Source: Vaccines, Vol 4, Iss 3, p 30 (2016)

Subject Terms: memory cell, Tregs, HIV, vaccine, DC-based vaccine, OX40, CD25, CD39, hu-mice, Medicine

File Description: electronic resource

Relation: http://www.mdpi.com/2076-393X/4/3/30; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/86dcbd55882749c38f74986bb62090e8

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.